Sarah Grimwood

Sarah Grimwood

Pfizer Inc. - New York / United States
Medical and Health Sciences / Neuroscience
AD Scientific Index ID: 4381818
-
person_outline Sarah Grimwood's MOST POPULAR ARTICLES
1-) 4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptorPD Leeson, RW Carling, KW Moore, AM Moseley, JD Smith, G Stevenson, ...Journal of medicinal chemistry 35 (11), 1954-1968, 20022502002
2-) Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development …L Zhang, A Villalobos, EM Beck, T Bocan, TA Chappie, L Chen, ...Journal of medicinal chemistry 56 (11), 4568-4579, 20131732013
3-) Identification of molecular determinants that are important in the assembly of N-methyl-D-aspartate receptorsE Meddows, B Le Bourdelles, S Grimwood, K Wafford, S Sandhu, ...Journal of Biological Chemistry 276 (22), 18795-18803, 20011622001
4-) Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonistsM Rowley, JJ Kulagowski, AP Watt, D Rathbone, GI Stevenson, ...Journal of medicinal chemistry 40 (25), 4053-4068, 19971711997
5-) 2-Carboxytetrahydroquinolines. Conformational and stereochemical requirements for antagonism of the glycine site on the N-methyl-D-aspartate (NMDA) receptorRW Carling, PD Leeson, AM Moseley, R Baker, AC Foster, S Grimwood, ...Journal of medicinal chemistry 35 (11), 1942-1953, 19921361992